Skip to content

Lobbying by EMD Serono: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

EMD Serono

Meetings this Parliament
5
With MPs
2
Since Nov 2021
5
Active registrations
1

Most recent reported meeting: Sep 15, 2026.

Who they meet

Since the current Parliament opened.

MPs

Institutions

  • Health Canada (HC)4
  • House of Commons2

Registrations in effect

Consultant In effect since Oct 20, 2025

Consultant Azin Peyrow of NATIONAL Public Relations Inc.

Consultant lobbyists

  • Azin Peyrow
  • Azin Peyrow

Institutions they may lobby: Finance Canada (FIN), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Public Health Agency of Canada (PHAC), Senate of Canada

What they're lobbying on (3)
  • EMD Serono is exploring Health Canada’s regulatory modernization and accelerated pathways for rare diseases. EMD Serono wants to collaborate with the government in shaping a competitive rare disease strategy that works for Canadians, in light of the increasingly competitive global landscape. EMD Serono wants to collaborate with the government in shaping a competitive rare disease strategy that works for Canadians and stands out globally
  • EMD Serono supports the Government of Canada's commitment to funding fertility treatment. As part of its outreach, EMD Serono is calling on the federal government to advance this commitment in Budget 2025.
  • EMD Serono is working towards establishing long-lasting relationships with government. EMD Serono will be meeting with targeted government officials and agencies to provide an overview of their current treatment offering and how they have supported Canadian patients over the years. As an industry leader in the healthcare space, EMD Serono would like to build trust with government and be available to support with future decision making in their key therapeutic areas, where possible.

Registration 954646-381450-2. Look it up in the official Registry

Reported meetings

Spreadsheet

  • Reported by Azin Peyrow · Consultant

    • Justine Frame · Policy Advisor, Health Canada (HC)
    • Fatoumatah Bah · Policy Advisor, Health Canada (HC)
    EMD Serono supports the Government of Canada's commitment to funding fertility treatment. As part of its outreach, EMD Serono is calling on the federal government to advance this commitment in Budget 2025. Read more

    EMD Serono is exploring Health Canada’s regulatory modernization and accelerated pathways for rare diseases. EMD Serono wants to collaborate with the government in shaping a competitive rare disease strategy that works for Canadians, in light of the increasingly competitive global landscape. EMD Serono wants to collaborate with the government in shaping a competitive rare disease strategy that works for Canadians and stands out globally

    Official report

  • Reported by Azin Peyrow · Consultant

    • Justine Frame · Policy Advisor, Health Canada (HC)
    EMD Serono is working towards establishing long-lasting relationships with government. EMD Serono will be meeting with targeted government officials and agencies to provide an overview of their current treatment offering and how they have supported Canadian patients over the years. As an industry leader in the healthcare space, EMD Serono would like to build trust with government and be available to support with future decision making in their key therapeutic areas, where possible. Read more

    Official report

  • Reported by Azin Peyrow · Consultant

    • Maggie Chi · Parliamentary Secretary to the Health Minister
    • Nora Draper · Parliamentary Secretary Assistant, Health Canada (HC)
    • Shanzae Khan · Senior Special Assistant, Ontario Desk, Health Canada (HC)
    EMD Serono is exploring Health Canada’s regulatory modernization and accelerated pathways for rare diseases. EMD Serono wants to collaborate with the government in shaping a competitive rare disease strategy that works for Canadians, in light of the increasingly competitive global landscape. EMD Serono wants to collaborate with the government in shaping a competitive rare disease strategy that works for Canadians and stands out globally Read more

    EMD Serono supports the Government of Canada's commitment to funding fertility treatment. As part of its outreach, EMD Serono is calling on the federal government to advance this commitment in Budget 2025.

    EMD Serono is working towards establishing long-lasting relationships with government. EMD Serono will be meeting with targeted government officials and agencies to provide an overview of their current treatment offering and how they have supported Canadian patients over the years. As an industry leader in the healthcare space, EMD Serono would like to build trust with government and be available to support with future decision making in their key therapeutic areas, where possible.

    Official report

  • Reported by Azin Peyrow · Consultant

    • Dan Mazier · Member of Parliament
    • Kieran Steede · Office of Dan Mazier, House of Commons
    EMD Serono is exploring Health Canada’s regulatory modernization and accelerated pathways for rare diseases. EMD Serono wants to collaborate with the government in shaping a competitive rare disease strategy that works for Canadians, in light of the increasingly competitive global landscape. EMD Serono wants to collaborate with the government in shaping a competitive rare disease strategy that works for Canadians and stands out globally Read more

    EMD Serono is working towards establishing long-lasting relationships with government. EMD Serono will be meeting with targeted government officials and agencies to provide an overview of their current treatment offering and how they have supported Canadian patients over the years. As an industry leader in the healthcare space, EMD Serono would like to build trust with government and be available to support with future decision making in their key therapeutic areas, where possible.

    EMD Serono supports the Government of Canada's commitment to funding fertility treatment. As part of its outreach, EMD Serono is calling on the federal government to advance this commitment in Budget 2025.

    Official report

  • Reported by Azin Peyrow · Consultant

    • Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
    EMD Serono is working towards establishing long-lasting relationships with government. EMD Serono will be meeting with targeted government officials and agencies to provide an overview of their current treatment offering and how they have supported Canadian patients over the years. As an industry leader in the healthcare space, EMD Serono would like to build trust with government and be available to support with future decision making in their key therapeutic areas, where possible. Read more

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.